selegiline has been researched along with Recrudescence in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Craig Nelson, J; Jang, S; Jung, S; Kimberly, BP; Pae, C; Patkar, AA | 1 |
| Bryson, SW; Fong, D; Fortmann, SP; Hayward, C; Killen, DT; Killen, JD; Lowenthal, K; Murphy, GM; Schatzberg, AF | 1 |
2 trial(s) available for selegiline and Recrudescence
| Article | Year |
|---|---|
Predictors of relapse in patients with major depressive disorder in a 52-week, fixed dose, double blind, randomized trial of selegiline transdermal system (STS).
Topics: Administration, Cutaneous; Adult; Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Monoamine Oxidase Inhibitors; Proportional Hazards Models; Recurrence; Risk Factors; Selegiline | 2013 |
Failure to improve cigarette smoking abstinence with transdermal selegiline + cognitive behavior therapy.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Behavior Therapy; Breath Tests; Carbon Monoxide; Female; Humans; Kaplan-Meier Estimate; Male; Medication Adherence; Middle Aged; Monoamine Oxidase Inhibitors; Motivation; Recurrence; Regression Analysis; Selegiline; Sex Distribution; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome; Young Adult | 2010 |